Return to Statistics Toolbox

OPLS-DA analysis for Study ST001232

(Analysis AN002050 )

Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Drug treatment:ATQ-04072018
Drug treatment:ATQ-05102017
Drug treatment:ATQ-06022018
Drug treatment:ATQ-11022019
Drug treatment:ATQ-11102018
Drug treatment:ATQ-16032017
Drug treatment:ATQ-18012018
Drug treatment:ATQ-18102017
Drug treatment:ATQ-21062017
Drug treatment:ATQ-22092017
Drug treatment:ATQ-26072017
Drug treatment:ATQ-27062018
Drug treatment:ATQ-29062017
Drug treatment:DHA-30012018
Drug treatment:Ferroquine-06022018
Drug treatment:GNF-Pf-5660-27062018
Drug treatment:KAI407-29062017
Drug treatment:Lumefantrine-30012018
Drug treatment:Mefloquine-30012018
Drug treatment:MethyleneBlue-18012018
Drug treatment:MMV000442-18102017
Drug treatment:MMV000787-22092017
Drug treatment:MMV007181-05102017
Drug treatment:MMV007181-22092017
Drug treatment:MMV019555-04072018
Drug treatment:MMV019555-26072017
Drug treatment:MMV020746-21062017
Drug treatment:MMV020746-22092017
Drug treatment:MMV021735-11102018
Drug treatment:MMV022224-11102018
Drug treatment:MMV022478-11022019
Drug treatment:MMV027496-11102018
Drug treatment:MMV030666-11102018
Drug treatment:MMV085071-04072018
Drug treatment:MMV665794-16032017
Drug treatment:MMV665939-21062017
Drug treatment:MMV667491-22092017
Drug treatment:MMV668311-11022019
Drug treatment:MMV675939-21062017
Drug treatment:MMV675939-22092017
Drug treatment:Naphthoquine-30012018
Drug treatment:No treatment
Drug treatment:Pipquine-18012018
Drug treatment:Treated with no drug
Drug treatment:WLL-11022019

  logo